newsfilter
← Latest News
GlobeNewswire·

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

- Cyclacel Expects to Release Updated Phase 1/2 Clinical and Biomarker Data with Oral Fadraciclib and Provide Safety, Efficacy and Putative Mechanism Update for Oral Plogosertib - - Management to Host Conference Call at